#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14954	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2110	704.8	0	.	n	.	0	C451T	SNP	451	451	C	720	720	T	871	T,C	623,190	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14954	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2110	704.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1453	1453	C	874	C	820	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14954	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2110	704.8	0	HET	.	.	.	C207T	.	207	207	C	476	476	C	820	C,T	587,176	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27616	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3600	764.4	0	.	n	.	0	T695C	SNP	695	695	T	1090	1090	C	837	C	793	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27616	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3600	764.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2366	2366	C	920	C,T	858,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27616	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3600	764.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2440	2440	A	919	A	876	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27616	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3600	764.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2992	2992	C	827	C	790	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27616	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3600	764.4	0	HET	.	.	.	A1638G	.	1638	1638	A	2033	2033	A	903	A,G	610,246	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1922	folP	855	855	100.0	folP.l15.c4.ctg.1	1495	127.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1018	1020	AGC	186;183;183	A;G;C	180;178;177	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5210	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3477	149.5	1	SNP	p	S91F	1	.	.	271	273	TTC	601	603	TTC	174;175;174	T;T;C	162;165;162	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5210	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3477	149.5	1	SNP	p	G95N	0	.	.	283	285	GGC	613	615	GGC	169;167;163	G;G;C	156;155;154	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5210	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3477	149.5	1	SNP	p	D95G	1	.	.	283	285	GGC	613	615	GGC	169;167;163	G;G;C	156;155;154	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1550	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1420	108.9	1	SNP	p	G45D	0	.	.	133	135	GGC	561	563	GGC	177;175;174	G;G;C	167;163;164	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	736	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1017	72.2	0	.	n	.	0	A197.	DEL	197	197	A	595	595	A	164	A	157	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5684	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2946	192.2	1	SNP	p	D86N	0	.	.	256	258	GAC	581	583	GAC	244;245;247	G;A,T;C	221;218,1;221	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5684	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2946	192.2	1	SNP	p	R87I	0	.	.	259	261	CGT	584	586	CGT	247;249;252	C;G;T	225;228;226	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5684	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2946	192.2	1	SNP	p	R87W	0	.	.	259	261	CGT	584	586	CGT	247;249;252	C;G;T	225;228;226	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5684	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2946	192.2	1	SNP	p	S87R	1	.	.	259	261	CGT	584	586	CGT	247;249;252	C;G;T	225;228;226	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5684	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2946	192.2	1	SNP	p	S88P	0	.	.	262	264	TCC	587	589	TCC	253;254;254	T;C;C	230;229;228	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3994	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2770	143.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1549	1551	GGC	193;188;189	G;G;C	183;178;178	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3868	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2427	158.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1281	1283	GCC	181;178;179	G;C;C	172;168;170	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3868	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2427	158.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1284	1286	ATG	184;185;185	A;T;G	173;174;173	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3868	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2427	158.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1296	1298	ACC	177;180;180	A;C,A;C	168;169,1;168	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3868	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2427	158.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1296	1298	ACC	177;180;180	A;C,A;C	168;169,1;168	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3868	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2427	158.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1797	1799	ACC	233;233;233	A;C;C	215;219;221	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3868	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2427	158.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1851	1853	GCG	220;222;224	G;C,T;G	208;207,1;211	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3868	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2427	158.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1851	1853	GCG	220;222;224	G;C,T;G	208;207,1;211	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3868	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2427	158.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1974	1976	GGT	178;176;175	G;G;T	164;164;163	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3868	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2427	158.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1983	1985	AGC	169;168;167	A;G;C	154;154;151	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3868	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2427	158.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2001	2003	CCG	143;143;142	C,G;C;G,GGC	120,2;118;120,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5730	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3173	180.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1616	1618	CCG	203;204;205	C;C;G	182;191;186	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2580	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1781	143.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	569	569	C	183	C	165	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	310	porB1a	984	280	90.85	porB1a.l6.c30.ctg.2	283	34.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	21	23	AAT	11;11;12	A;A;T	3;3;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	310	porB1a	984	280	90.85	porB1a.l6.c30.ctg.2	283	34.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	24	26	AAT	12;12;12	A;A;T	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	310	porB1a	984	280	90.85	porB1a.l6.c30.ctg.2	283	34.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	48	50	GCA	12;12;12	G;C;A	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	310	porB1a	984	280	90.85	porB1a.l6.c30.ctg.2	283	34.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	71	73	GTA	8;9;9	G;T;A	7;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	310	porB1a	984	280	90.85	porB1a.l6.c30.ctg.2	283	34.3	0	.	p	.	0	N237fs	FSHIFT	709	709	A	80	80	A	9	A	9	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2810	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1582	176.7	0	.	p	.	0	G210R	NONSYN	628	630	GGA	900	902	AGA	230;229;232	A,T;G;A	219,1;219;222	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2810	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1582	176.7	0	.	p	.	0	S217G	NONSYN	649	651	AGT	921	923	GGT	231;230;231	G;G;T	227;223;224	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2810	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1582	176.7	1	SNP	p	G120K	1	.	.	358	360	AAG	630	632	AAG	184;186;188	A;A;G	175;179;177	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2810	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1582	176.7	1	SNP	p	N121D	0	.	.	361	363	AAC	633	635	AAC	187;190;192	A;A;C	182;184;184	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2810	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1582	176.7	1	SNP	p	A121N	1	.	.	361	363	AAC	633	635	AAC	187;190;192	A;A;C	182;184;184	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10810	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4816	223.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1124	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1052	106.3	1	SNP	p	V57M	1	.	.	169	171	ATG	536	538	ATG	248;247;245	A;T;G	229;230;228	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
